| View |
|
DRP-6810-12
|
Co-Amoxiclav
|
Bluemox
|
625 mg
|
Film-Coated Tablet
|
Antibacterial(Penicillin-Beta-Lactamase Inhibitor Combination)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
06 October 2022
|
26 August 2026
|
| View |
|
DRP-9244-05
|
Salbutamol (as sulfate)
|
Oranair
|
1 mg/mL (2.5 mg/2.5 mL)
|
Solution for Inhalation
|
Bronchodilator (Selective beta-2-adrenoreceptor agonist)
|
Legency Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 October 2022
|
09 June 2025
|
| View |
|
DRP-12764
|
Prednisolone (as sodium phosphate)
|
None
|
20 mg / 5 mL
|
Oral Solution (Orange Flavor)
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
PCPR Conversion
|
06 October 2022
|
19 July 2026
|
| View |
|
DRP-12768
|
Sugammadex (as Sodium)
|
None
|
100 mg/mL (200 mg/2mL)
|
Solution for Injection (IV)
|
-
|
USV Private Limited
|
India
|
PCPR Conversion
|
06 October 2022
|
18 July 2027
|
| View |
|
DRP-7657-03
|
Rosuvastatin (as Calcium)
|
None
|
10mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Bafna Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
05 October 2022
|
08 March 2026
|
| View |
|
DRP-9314-05
|
Rosuvastatin (as calcium)
|
Jiaavast-10
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
05 October 2022
|
25 November 2025
|
| View |
|
DRP-10881-01
|
Trimetazidine hydrochloride
|
None
|
35mg
|
Modified Release Tablet
|
Anti-angina (Fatty Acid Oxidation [pFOX] Inhibitor)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
05 October 2022
|
10 December 2026
|
| View |
|
DRP-12762
|
TAMSULOSIN HYDROCHLORIDE
|
BETTAM
|
400 mcg
|
Prolonged-Release Capsule
|
Alpha-1-Adrenoceptor Antagonist
|
Sydler Remedies Pvt Ltd
|
India
|
Renewal
|
29 May 2023
|
03 June 2028
|
| View |
|
DRP-12763
|
Prednisolone (as sodium phosphate)
|
None
|
15 mg/ 5 mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
PCPR Conversion
|
05 October 2022
|
19 October 2026
|
| View |
|
DRP-3348-01
|
Glimepiride
|
Amara
|
2 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
20 March 2024
|
03 November 2029
|
| View |
|
DRP-8888-01
|
Oxaliplatin
|
Innoxaplin 100
|
2 mg/mL
|
Concentrate Solution for IV Infusion
|
Antioneoplastic agent
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
04 October 2022
|
02 July 2025
|
| View |
|
DRP-9315-06
|
Rosuvastatin (as calcium)
|
Jiaavast-20
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 October 2022
|
25 November 2025
|
| View |
|
DRP-12408-03
|
Cefalexin (as monohydrate)
|
Rapelex
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 October 2022
|
21 July 2027
|
| View |
|
DRP-12753
|
Ambroxol Hydrochloride
|
None
|
30 mg
|
Tablet
|
-
|
Shandong Yuxin Pharmaceutical Co., Ltd
|
China
|
PCPR Conversion
|
04 October 2022
|
25 May 2027
|
| View |
|
BRP-116
|
Filgrastim
|
Topneuter
|
150 mcg/mL
|
Solution for Injection (IV/SC)
|
-
|
Xiamen Amoytop Biotech Co., Ltd.
|
China
|
PCPR Conversion
|
03 October 2022
|
24 August 2026
|
| View |
|
DRP-2470-12
|
CLOPIDOGREL
|
NOCLOT
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
20 October 2024
|
05 February 2030
|
| View |
|
DRP-4433-02
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Muravit B150
|
150 mg/ 150 mg/ 200 mcg
|
Capsule
|
Vitamins
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
|
12 June 2023
|
23 May 2028
|
| View |
|
DRP-5800-16
|
Amlodipine (as Besilate)
|
Kodapine
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
02 November 2024
|
14 November 2029
|
| View |
|
DRP-5903-08
|
Vitamin B-Complex + Iron + Buclizine Hydrochloride
|
Muravit Booster
|
(see formulation on reverse side)
|
Capsule
|
Multivitamins
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
23 December 2024
|
| View |
|
DRP-5926-04
|
Cefixime (as Trihydrate)
|
Mexime
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
03 October 2022
|
12 October 2026
|